Neuropathie of zenuwlijden vormt een aanslag op het leven van vele diabetici. Schijnbaar moeten de verst afgelegen zenuwcellen in de voeten en de handen het als eerste ontgelden, mogelijk omdat zenuwcellen nu eenmaal zo veeleisend zijn, mogelijk omdat het een gevolg is van een pathologie van de kleinste bloedvaten. In dit overzicht bespreken we nutriënten en kruidenpreparaten die potentie hebben om de voortgang van neuropathie af te remmen.
Beste bezoeker, u heeft geen toegang.
Enkel (web)abonnees hebben toegang tot tijdschriftartikelen. Het webabonnement is nog in de maak.
U kunt zich wel alvast (gratis) registreren en tal van andere webartikelen raadplegen!
Auteur
Figuren
Verschenen in
Referenties
Bondar A, Popa AR, Papanas N, et al. Diabetic neuropathy: A narrative review of risk factors, classification, screening and current pathogenic treatment options (Review). Exp Ther Med. 2021; 22(1):690.
Duque A, Mediano MFF, De Lorenzo A, et al. Cardiovascular autonomic neuropathy in diabetes: Pathophysiology, clinical assessment and implications. World J Diabetes. 2021 Jun 15;12(6):855-867.
Sagesaka H, Sato Y, Someya Y, et al. Type 2 Diabetes: When Does It Start? J Endocr Soc. 2018 Apr 18;2(5):476-484.
Kirthi V, Perumbalath A, Brown E, et al. Prevalence of peripheral neuropathy in pre-diabetes: a systematic review. BMJ Open Diabetes Res Care. 2021; 9(1).
Sloan G, Selvarajah D, Tesfaye S. Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy. Nat Rev Endocrinol. 2021; 17(7):400-420.
Schreiber AK, Nones CF, Reis RC, et al. Diabetic neuropathic pain: Physiopathology and treatment. World J Diabetes. 2015 Apr 15;6(3):432-44.
Feldman EL, Callaghan BC, Pop-Busui R, et al. Diabetic neuropathy. Nat Rev Dis Primers. 2019 Jun 13;5(1):41.
Gouveri E, Papanas N. The Emerging Role of Continuous Glucose Monitoring in the Management of Diabetic Peripheral Neuropathy: A Narrative Review. Diabetes Ther. 2022; 13(5):931-952.
Han T, Bai J, Liu W, et al. A systematic review and meta-analysis of α-lipoic acid in the treatment of diabetic peripheral neuropathy. Eur J Endocrinol. 2012; 167(4):465-71.
Reljanovic M, Reichel G, Rett K, et al. Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (α-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy. Free Radical Research. 1999; 31:171–179.
Ziegler D, Hanefeld M, Ruhnau KJ, et al. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant α-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study). Diabetologia. 1995; 38:1425–1433.
Ziegler D, Hanefeld M, Ruhnau KJ, et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant α-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy. Diabetes Care. 1999; 22:1296–1301.
Ziegler D, Ametov A, Barinov A, et al. Oral treatment with α-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care. 2006; 29:2365–2370.
Agathos E, Tentolouris A, Eleftheriadou I, et al. Effect of α-lipoic acid on symptoms and quality of life in patients with painful diabetic neuropathy. J Int Med Res. 2018; 46(5):1779-1790.
Karalis DT, Karalis T, Karalis S, et al. The Effect of Alpha-Lipoic Acid on Diabetic Peripheral Neuropathy and the Upcoming Depressive Disorders of Type II Diabetics. Cureus. 2021; 13(1):e12773.
Xu Q, Pan J, Yu J, et al. Meta-analysis of methylcobalamin alone and in combination with lipoic acid in patients with diabetic peripheral neuropathy. Diabetes Res Clin Pract. 2013; 101(2):99-105.
Beltramo E, Mazzeo A, Porta M. Thiamine and diabetes: back to the future? Acta Diabetol. 2021; 58(11):1433-1439.
Karaganis S, Song XJ. B vitamins as a treatment for diabetic pain and neuropathy. J Clin Pharm Ther. 2021 Oct;46(5):1199-1212.
Khalil H, Ang CD, Khalil V. Vitamin B for treating diabetic peripheral neuropathy – A systematic review. Diabetes Metab Syndr. 2021 Sep-Oct;15(5):102213.
Jia HY, Tian HM, Wei D. Effects of methylcobalamin on diabetic peripheral neuropathy: a systematic review. Chinese Journal of Evidence-Based Medicine 2005; 5(8): 609-617.
Sawangjit R, Thongphui S, Chaichompu W, et al. Efficacy and Safety of Mecobalamin on Peripheral Neuropathy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Altern Complement Med. 2020; 26(12):1117-1129.
Didangelos T, Karlafti E, Kotzakioulafi E, et al. Vitamin B12 Supplementation in Diabetic Neuropathy: A 1-Year, Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients. 2021; 13(2).
Gwathmey KG, Grogan J. Nutritional neuropathies. Muscle Nerve. 2020; 62(1):13-29.
Vrolijk MF, Opperhuizen A, Jansen EHJM, et al. The vitamin B6 paradox: Supplementation with high concentrations of pyridoxine leads to decreased vitamin B6 function. Toxicol In Vitro. 2017; 44:206-212.
Pittas AG, Dawson-Hughes B, Sheehan P, et al. Vitamin D Supplementation and Prevention of Type 2 Diabetes. N Engl J Med. 2019 Aug 8;381(6):520-530.
Gröber U, Holick MF. Diabetes Prevention: Vitamin D Supplementation May Not Provide Any Protection If There Is No Evidence of Deficiency! Nutrients. 2019 Nov 4;11(11):2651.
Karonova T, Stepanova A, Bystrova A, et al. High-Dose Vitamin D Supplementation Improves Microcirculation and Reduces Inflammation in Diabetic Neuropathy Patients. Nutrients. 2020; 12(9).
Ghadiri-Anari A, Mozafari Z, Gholami S, et al. Dose vitamin D supplementations improve peripheral diabetic neuropathy? A before-after clinical trial. Diabetes Metab Syndr. ; 13(1):890-893.
Hor CP, Fung WY, Ang HA. Efficacy of Oral Mixed Tocotrienols in Diabetic Peripheral Neuropathy: A Randomized Clinical Trial. JAMA Neurol. 2018; 75(4):444-452.
Ng YT, Phang SCW, Tan GCJ, et al. The Effects of Tocotrienol-Rich Vitamin E (Tocovid) on Diabetic Neuropathy: A Phase II Randomized Controlled Trial. Nutrients. 2020; 12(5).
Rolim LC, da Silva EM, Flumignan RL, et al. Acetyl-L-carnitine for the treatment of diabetic peripheral neuropathy. Cochrane Database Syst Rev. 2019; 6:CD011265.
Oliveira-Abreu K, Cipolla-Neto J, Leal-Cardoso JH. Effects of Melatonin on Diabetic Neuropathy and Retinopathy. Int J Mol Sci. 2021; 23(1).
Lewis EJH, Perkins BA, Lovblom LE, et al. Effect of omega-3 supplementation on neuropathy in type 1 diabetes: A 12-month pilot trial. Neurology. 2017; 88(24):2294-2301.
Akbari Fakhrabadi M, Zeinali Ghotrom A, Mozaffari-Khosravi H, et al. Effect of Coenzyme Q10 on Oxidative Stress, Glycemic Control and Inflammation in Diabetic Neuropathy: A Double Blind Randomized Clinical Trial. Int J Vitam Nutr Res. 2014; 84(5-6):252-60.
Gregersen G, Bertelsen B, Harbo H et al. Oral supplementation of myoinositol: effects on peripheral nerve function in human diabetics and on the concentration in plasma, erythrocytes, urine and muscle tissue in human diabetics and normals. Acta Neurol Scand. 1983; 67(3):164-72.
Didangelos T, Karlafti E, Kotzakioulafi E, et al. Efficacy and Safety of the Combination of Superoxide Dismutase, Alpha Lipoic Acid, Vitamin B12, and Carnitine for 12 Months in Patients with Diabetic Neuropathy. Nutrients. 2020; 12(11).
Kharitonova T, Shvarts YG, Verbovoy AF, et al. Efficacy and safety of the combined metabolic medication, containing inosine, nicotinamide, riboflavin and succinic acid, for the treatment of diabetic neuropathy: a multicenter randomized, double-blind, placebo-controlled parallel group clinical trial (CYLINDER). BMJ Open Diabetes Res Care. 2022; 10(3).
Veeresham C, Rama Rao A, Asres K. Aldose reductase inhibitors of plant origin. Phytother Res. 2014; 28(3):317-33.
Valensi P, Le Devehat C, Richard JL, et al. A multicenter, double-blind, safety study of QR-333 for the treatment of symptomatic diabetic peripheral neuropathy. A preliminary report. J Diabetes Complications 2005; 19(5):247-53.
Deng Z, Wang M, Fan Y, et al. Salviae miltiorrhizae and ligustrazine hydrochloride injection combined with mecobalamin for treating diabetic peripheral neuropathy: A protocol for systematic review and meta-analysis. Medicine (Baltimore). 2021; 100(3):e24103.
Chen W, Zhang Y, Li X, et al. Chinese herbal medicine for diabetic peripheral neuropathy. Cochrane Database Syst Rev. 2013 Oct 6;(10):CD007796.
Jo HG, Lee D. Oral Administration of East Asian Herbal Medicine for Peripheral Neuropathy: A Systematic Review and Meta-Analysis with Association Rule Analysis to Identify Core Herb Combinations. Pharmaceuticals (Basel). 2021; 14(11).
Boyd A, Bleakley C, Hurley DA, et al. Herbal medicinal products or preparations for neuropathic pain. Cochrane Database Syst Rev. 2019; 4:CD010528.
D’Souza RS, Barman R, Joseph A, et al. Evidence-Based Treatment of Painful Diabetic Neuropathy: a Systematic Review. Curr Pain Headache Rep. 2022 Jun 18.
Heydari M, Homayouni K, Hashempur MH, et al. Topical Citrullus colocynthis (bitter apple) extract oil in painful diabetic neuropathy: A double-blind randomized placebo-controlled clinical trial. J Diabetes. 2016; 8(2):246-52.
Wallace MS, Marcotte TD, Umlauf A, et al. Efficacy of Inhaled Cannabis on Painful Diabetic Neuropathy. J Pain. 2015; 16(7):616-27.
Wallace MS, Marcotte TD, Atkinson JH, et al. A Secondary Analysis from a Randomized Trial on the Effect of Plasma Tetrahydrocannabinol Levels on Pain Reduction in Painful Diabetic Peripheral Neuropathy. J Pain. 2020; 21(11-12):1175-1186.
Xu DH, Cullen BD, Tang M, et al. The Effectiveness of Topical Cannabidiol Oil in Symptomatic Relief of Peripheral Neuropathy of the Lower Extremities. Curr Pharm Biotechnol. 2020; 21(5):390-402.
Perrin BM, Southon J, McCaig J, et al. The Effect of Structured Exercise Compared with Education on Neuropathic Signs and Symptoms in People at Risk of Neuropathic Diabetic Foot Ulcers: A Randomized Clinical Trial. Medicina (Kaunas). 2021; 58(1).
Ghavami H, Radfar M, Soheily S, et al. Effect of lifestyle interventions on diabetic peripheral neuropathy in patients with type 2 diabetes, result of a randomized clinical trial. Agri. 2018; 30(4):165-170.
Pennathur S, Jaiswal M, Vivekanandan-Giri A, et al. Structured lifestyle intervention in patients with the metabolic syndrome mitigates oxidative stress but fails to improve measures of cardiovascular autonomic neuropathy. J Diabetes Complications. 2017; 31(9):1437-1443.
